Cell Stiffness Is a Biomarker of the Metastatic Potential of Ovarian Cancer Cells

I tiakina i:
Ngā taipitopito rārangi puna kōrero
I whakaputaina i:PLoS One vol. 7, no. 10 (Oct 2012), p. e46609
Kaituhi matua: Xu, Wenwei
Ētahi atu kaituhi: Mezencev, Roman, Kim, Byungkyu, Wang, Lijuan, McDonald, John, Sulchek, Todd
I whakaputaina:
Public Library of Science
Ngā marau:
Urunga tuihono:Citation/Abstract
Full Text
Full Text - PDF
Ngā Tūtohu: Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
Whakaahuatanga
Whakarāpopotonga:The metastatic potential of cells is an important parameter in the design of optimal strategies for the personalized treatment of cancer. Using atomic force microscopy (AFM), we show, consistent with previous studies conducted in other types of epithelial cancer, that ovarian cancer cells are generally softer and display lower intrinsic variability in cell stiffness than non-malignant ovarian epithelial cells. A detailed examination of highly invasive ovarian cancer cells (HEY A8) relative to their less invasive parental cells (HEY), demonstrates that deformability is also an accurate biomarker of metastatic potential. Comparative gene expression analyses indicate that the reduced stiffness of highly metastatic HEY A8 cells is associated with actin cytoskeleton remodeling and microscopic examination of actin fiber structure in these cell lines is consistent with this prediction. Our results indicate that cell stiffness may be a useful biomarker to evaluate the relative metastatic potential of ovarian and perhaps other types of cancer cells.
ISSN:1932-6203
DOI:10.1371/journal.pone.0046609
Puna:Health & Medical Collection